Native Patellar Tendon Research Articles

A Novel Patellar Tendon Reconstruction Technique Using Semitendinosus Allograft

A Novel Patellar Tendon Reconstruction Technique Using Semitendinosus Allograft

Extensor mechanism ruptures.

Native patellar tendon injuries are seen in younger patients compared to quadriceps tendon ruptures.Up to a third of the patients may have local (antecedent tendinopathy and cortisone injections) or systemic risk factors (obesity, diabetes, hyperparathyroidism, chronic renal failure, fluoroquinolone or statin use) of injury, these are more frequent in bilateral disruptions.Complete extensor mechanism disruptions should be repaired surgically. Although isolated primary repair has been reported to have good outcomes in younger patients with acute tears and good tendon quality, augmentation of the repair with autograft, allograft or synthetic material should be considered in patients with poor tendon quality, chronic tears or tendon defects.High rates of return to work/sports have been reported in native patellar and quadriceps tendon tears, with re-rupture rates <5%.Extensor mechanism disruptions in patients with a total knee arthroplasty are challenging due to older age, systemic co-morbidities and poor local conditions, resulting in inferior outcomes compared to native extensor mechanism injuries. Some form of augmentation with autograft, allograft or synthetics is advisable in all cases. Salvage procedures such as whole extensor mechanism allografts provide acceptable outcomes in multiply operated knees with extensive bone and soft tissue deficits.

Successful mid- to long-term outcome after reconstruction of the extensor apparatus using proximal tibia-patellar tendon composite allograft.

The purpose of the study was to assess the outcomes of extensor mechanism reconstruction with proximal tibia-patellar tendon composite allograft. 24 consecutive patients treated with allograft-prosthetic composite for proximal tibia tumour resection and a conventional total knee arthroplasty were included. Extensor mechanism reconstruction was performed with a proximal tibia-patellar tendon composite allograft and the suture of the donor tendon to the remnant native patellar tendon. Function was evaluated by the Musculoskeletal Tumor Society score (MSTS) and range of motion. Western Ontario and MacMaster University (WOMAC) and visual analogue scale for pain also were used. After a mean follow-up of 11.7 (range 3-15) years, mean MSTS score was 22.4 (range 20-30), mean flexion was 94.0° (range 84°-110°), and mean extension lag was 7.2° (range 0°-18°). The mean VAS-pain was 4.3 (range 2-6), and WOMAC score was 72.4 (range 58-100). There was no failure of the reconstructed extensor mechanism. Patellar tendon reconstruction with allogeneic tissue from the proximal tibia allograft sutured to the recipient's remnant patellar tendon provides the mechanical support needed for healing of the reconstructed extensor mechanism with a substantial functional benefit to stabilize active knee extension and successful reconstruction survival at long-term. III.

Anterior Cruciate Ligament Reconstruction Basics: Bone–Patellar Tendon–Bone Autograft Harvest

Anterior cruciate ligament reconstruction with bone–patellar tendon–bone autograft has long been considered the graft preference for young, active patients with anterior cruciate ligament injuries. The central-third of the native patellar tendon is a reliable graft and is the preferred option for competitive athletes given its excellent track record with high return-to-play rates and low failure rates. Disadvantages to using this graft include donor site morbidity and associated postoperative anterior knee pain, the risk of patellar fracture or patellar tendon tear, and the potential for graft-construct mismatch. In this Technical Note, we describe our preferred technique for bone–patellar tendon–bone autograft harvest and preparation for anterior cruciate ligament reconstruction.

Improved biomechanical and biological outcomes in the MRL/MpJ murine strain following a full-length patellar tendon injury.

Musculoskeletal injuries greatly affect the U.S. population and current clinical approaches fail to restore long-term native tissue structure and function. Tissue engineering is a strategy advocated to improve tendon healing; however, the field still needs to establish biological benchmarks for assessing the effectiveness of tissue-engineered structures. Investigating superior healing models, such as the MRL/MpJ, offers the opportunity to first characterize successful healing and then apply experimental findings to tissue-engineered therapies. This study seeks to evaluate the MRL/MpJ's healing response following a central patellar tendon injury compared to wildtype. Gene expression and histology were assessed at 3, 7, and 14 days following injury and mechanical properties were measured at 2, 5, and 8 weeks. Native patellar tendon biological and mechanical properties were not different between strains. Following injury, the MRL/MpJ displayed increased mechanical properties between 5 and 8 weeks; however, early tenogenic expression patterns were not different between the strains. Furthermore, expression of the cyclin-dependent kinase inhibitor, p21, was not different between strains, suggesting an alternative mechanism may be driving the healing response. Future studies will investigate collagen structure and alignment of the repair tissue and characterize the complete healing transcriptome to identify mechanisms driving the MRL/MpJ response.

Murine patellar tendon biomechanical properties and regional strain patterns during natural tendon-to-bone healing after acute injury

Tendon-to-bone healing following acute injury is generally poor and often fails to restore normal tendon biomechanical properties. In recent years, the murine patellar tendon (PT) has become an important model system for studying tendon healing and repair due to its genetic tractability and accessible location within the knee. However, the mechanical properties of native murine PT, specifically the regional differences in tissue strains during loading, and the biomechanical outcomes of natural PT-to-bone healing have not been well characterized. Thus, in this study, we analyzed the global biomechanical properties and regional strain patterns of both normal and naturally healing murine PT at three time points (2, 5, and 8weeks) following acute surgical rupture of the tibial enthesis. Normal murine PT exhibited distinct regional variations in tissue strain, with the insertion region experiencing approximately 2.5 times greater strain than the midsubstance at failure (10.80±2.52% vs. 4.11±1.40%; mean±SEM). Injured tendons showed reduced structural (ultimate load and linear stiffness) and material (ultimate stress and linear modulus) properties compared to both normal and contralateral sham-operated tendons at all healing time points. Injured tendons also displayed increased local strain in the insertion region compared to contralateral shams at both physiologic and failure load levels. 93.3% of injured tendons failed at the tibial insertion, compared to only 60% and 66.7% of normal and sham tendons, respectively. These results indicate that 8weeks of natural tendon-to-bone healing does not restore normal biomechanical function to the murine PT following injury.

Diabetes mellitus alters the mechanical properties of the native tendon in an experimental rat model

The purpose of this study was to determine the effect of the diabetic phenotype on the mechanical properties of the native patellar tendon and its enthesis. Diabetes was induced via intraperitoneal injection of streptozotocin in Lewis rats. Control (n = 18) and diabetic animals (n = 20) were killed at 12 and 19 days for analysis. Statistical comparisons were performed using Student's t-tests and a two-tailed Fisher test with significance set at p < 0.05. Pre- and post-injection intraperitoneal glucose tolerance tests demonstrated significant impairment of glycemic control in the diabetic compared to control animals (p = 0.001). Mean serum hemoglobin A1c levels at 19 days was 10.6 ± 2.7% and 6.0 ± 1.0% for the diabetic and control groups, respectively (p = 0.0001). Fifteen of sixteen diabetic animals demonstrated intrasubstance failure of the patellar tendon, while only 7 of 14 control specimens failed within the tendon substance. The Young's modulus of the diabetic tendon was significantly lower than control specimens by 19 days post-induction (161 ± 10 N m(-2) compared to 200 ± 46 N m(-2) , respectively) (p = 0.02). The metabolic condition of poorly controlled diabetes negatively affects the mechanical properties of the native patellar tendon. These altered structural properties may predispose diabetic patients to a greater risk of tendinopathy and/or traumatic rupture.

Papers Presented at the 2005 Meeting of the Musculoskeletal Tumor Society

Papers Presented at the 2005 Meeting of the Musculoskeletal Tumor Society

Is the increase in type III collagen of the patellar tendon graft after ligament reconstruction really caused by “ligamentization” of the graft?

To test the hypothesis that extrinsic cells that infiltrate the devitalized patellar tendon (PT) synthesize type III collagen even in the environmental milieu of the native PT, we conducted the present experimental study using the rat in situ frozen-thawed PTs. Tissue culture showed no cell outgrowth from the tendons immediately after the freeze-thaw treatment. Analysis by RT-PCR showed that the expression level of type III procollagen mRNA in the frozen-thawed tendon was significantly higher than that in the sham-operated tendon at 6 and 12 weeks. Immunohistological findings showed positive type III collagen staining around cells that had infiltrated the necrotized tendon at 3, 6, and 12 weeks. In addition, the elastic modulus of the in situ frozen-thawed tendon at 6 weeks was significantly less than that of the sham-operated tendon. The present study indicates that extrinsic cells that had infiltrated the devitalized PT synthesized type III collagen at least for 12 weeks even in the environmental milieu of the native PT. These findings raised the question whether the increase in type III collagen of the PT graft after ACL reconstruction is really caused by "ligamentization," the adaptation of the PT graft to the ACL environment.

Residual Strength of the Quadriceps Versus Patellar Tendon After Harvesting a Central Free Tendon Graft

Free tendon grafts for reconstruction of the anterior cruciate ligament have become more prevalent with the desire for reduced morbidity, earlier postoperative rehabilitation, and improved free tendon graft fixation. The central quadriceps tendon autograft is an alternative to bone-patellar tendon-bone and free hamstring autografts. The purpose of this study was to measure the postharvest reduction in quadriceps extensor mechanism strength when a central quadriceps free tendon graft is removed. The strength deficit was compared with that associated with harvesting a central free patellar tendon graft, excluding the effects of harvesting bone blocks. Experimental laboratory study. Fourteen knee extensor mechanisms were divided into quadriceps and patellar tendon constructs. Constructs were tested to failure in tension in either the intact state or after removing 10-mm wide central free tendon grafts. Failure strengths of the quadriceps and patellar tendon constructs were compared statistically using paired and unpaired t tests. The average strength (+/-SD) measured for the native quadriceps tendon was 3,660 +/- 830 N, decreasing to 2,430 +/- 680 N after removing a partial-thickness 10-mm wide central free graft. The average strength measured for the native patellar tendon was 1,920 +/- 330 N, decreasing to 1,460 +/- 740 N after removing a 10-mm wide central free graft. The tensile strength of the quadriceps tendon is reduced by approximately one third after harvesting a partial-thickness 10-mm wide central free tendon graft. This postharvest strength of the quadriceps tendon is higher than that of the intact patellar tendon. Surgeons can be assured that harvest of a central quadriceps free tendon graft leaves a stronger extensor mechanism than harvest of a patellar tendon graft.

Patellar Tendon-to-Bone Healing Using High-Density Collagen Bone Anchor at 4 Years in a Sheep Model

Background This study reports the long-term histologic and mechanical properties of the healing patellar tendon–bone interface reconstructed using a high-density type I collagen bone anchor (HDC) compared to a metal anchor in sheep. Hypothesis To determine the long-term histology and mechanical properties of extra-articular tendon-bone healing and in vivo response to a HDC anchor. Study Design Controlled laboratory study. Methods The structural properties, tendon-bone histology, and device histology in the bone were examined out to 208 weeks in a sheep model. Results The patellar tendon–proximal tibia bone interface continued to remodel with time but, by 4 years, had yet to develop the well-defined zones of tendon, fibrocartilage, calcified cartilage, and bone of the native patellar tendon to bone insertion. The insertion repair strength did not vary between the repaired tendons and the nonoperated controls at any time. Conclusion The healing tendon-bone interface undergoes a gradual remodeling process, which had yet to reconstitute back to the control interface by 208 weeks. The HDC device remained essentially intact at 208 weeks showing little signs of degradation. Clinical Relevance Tendon-bone healing is mechanically equivalent to the contralateral side by 26 weeks whereas histologic structure requires much longer to remodel back to the native insertion.

Effect of alignment of the transplanted graft extracellular matrix on cellular repopulation and newly synthesized collagen

This study examines the effect of alignment of the transplanted graft extracellular matrix on cellular repopulation and new collagen synthesis. The lateral half of the patellar tendon was harvested as a tendon graft from Lewis rats and frozen at -80 degrees C. In order to maintain the original alignment of the graft extracellular matrix, the graft was transplanted to a same size defect in the patellar tendon of other Lewis rats (group I). For controls, the graft was transplanted in a lax condition after excision of only the distal half of the lateral side of a patellar tendon (group II). After transplantation, six animals in each group were killed at 3, 7, 14, and 28 days. Cellular repopulation was assessed by using fibrillar-actin (F-actin) labeling with rhodamine-phalloidin, and new collagen synthesis was detected by means of a polyclonal antibody against type III collagen aminopropeptide (pN collagen III). Collagen fibril profiles were observed under the transmission electron microscope. On the 3rd day after transplantation, no specific fluorescence was detected in either group. Specific labeling for F-actin and pN collagen III, however, was observed at both ends of the graft in both groups at 1 week and throughout the graft at 2 weeks after transplantation. Consistent with the actin bundles' orientation, pN collagen III was aligned parallel to the longitudinal axis of the graft in group I. Collagen fibrils with a smaller diameter, mixed evenly and everywhere with a larger diameter, increased gradually in group I. However, smaller collagen fibrils in group II increased more slowly and were distributed unevenly. In summary, the dense collagen arrangement in the native patellar tendon determined the alignment of the repopulating cells, and the distribution of newly synthesized collagen might be affected by the actin cytoskeleton within the repopulating cells.

Alterations of glycosaminoglycans during patellar tendon autograft healing after posterior cruciate ligament replacement. A biochemical study in a sheep model.

In each of 30 skeletally mature sheep, the posterior cruciate ligament was replaced in one knee by a free patellar tendon autograft using the central third of the ipsilateral patellar tendon. The healing autograft was compared with the contralateral posterior cruciate ligament and the patellar tendons and posterior cruciate ligaments of nonoperated animals. The content of glycosaminoglycans, chondroitin sulfate disaccharides, and dermatan sulfate disaccharides was assessed biochemically at six periods during the 2 years after surgery. The total glycosaminoglycans and chondroitin sulfate disaccharides in the native posterior cruciate ligament was threefold that in the native patellar tendon. In contrast, the amount of dermatan sulfate disaccharides was similar in both the native tendon and native ligament. In the autograft, glycosaminoglycans and chondroitin sulfate disaccharides increased significantly to about 144% and 172%, respectively, of the contralateral posterior cruciate ligament at Week 104. The dermatan sulfate disaccharides in the autograft also showed a significant increase up to Week 26, followed by a remarkable but not significant decrease until the end of the study. In the contralateral posterior cruciate ligament, the dermatan sulfate disaccharides increased significantly between Weeks 52 and 104. Thus, the amount of dermatan sulfate disaccharides was similar in both the autograft and the contralateral posterior cruciate ligament after 2 years. This study suggests that the patellar tendon autograft did not completely assume the biochemical properties of the posterior cruciate ligament.

The natural history of the anterior cruciate ligament autograft of patellar tendon origin.

A rabbit model for ACL reconstruction using autogenous patellar tendon (PT) was used to study graft viability, its response to new physical forces, and the intrasynovial milieu. The autograft was assessed grossly, histologically, and biochemically with respect to time. Histologic observations demonstrated that autografts were centrally acellular with a peripheral rim of cells at 2 weeks, and had a central focal proliferation of cells at 3 weeks and cellular homogeneity by 4 weeks postoperation. Necrosis followed by cellular proliferation suggested that a population of cells other than the native PT fibroblasts may be inhabiting the graft. Graft sequestration experiments demonstrated that autografts are repopulated by cells of extrinsic origin after transplantation. Autografts showed a gradual assumption of the microscopic properties of normal ACL; by 30 weeks posttransplant the tissue characteristics were ligamentous in appearance. Histologic changes paralleled the biochemical metamorphosis: Type III collagen was not observed in PT; however, a gradual increase in its concentration was seen in the grafts; by 30 weeks its concentration (10%) was the same as in normal ACL. Similarly, glycosaminoglycan content increased from its normally low level in PT to that found in native ACL. Collagen-reducible cross-link analysis revealed that grafted tissue changed from the normal PT pattern of low dihydroxylysinonorleucine and high histidinohydroxymerodesmosine to the opposite pattern seen in normal ACL by 30 weeks. These data suggest that PT autografts undergo a process of "ligamentization" when placed in the ACL environment, and that cells responsible for this metamorphosis are of extragraft origin.

Origin of replacement cells for the anterior cruciate ligament autograft.

A rabbit model for anterior cruciate ligament (ACL) reconstruction using autogenous avascular patellar tendon (PT) was utilized to study the early events of graft incorporation. Histological observations demonstrated that autografts were centrally acellular with a peripheral rim of cells at 2 weeks, a central focal proliferation of cells at 3 weeks, and a cellular homogeneous distribution by 4-weeks postoperation. Graft necrosis followed by cellular proliferation suggested that a different population of cells other than the native PT fibroblasts may be inhabiting the graft. The extrinsic contribution of cells was studied by selective destruction of native PT cells with liquid nitrogen immersion prior to reconstruction of the ACL. The intrinsic contribution of cells was evaluated by sequestration of the PT graft in a semipermeable membrane before it was used to reconstruct the ACL. Histological analysis of tissue that was liquid N2 treated, used as an autograft, and then harvested 3-weeks postoperation revealed fibroblastic incorporation of the graft. In contrast, no cells were observed in semipermeable membrane sequestered autografts. These data suggest that autogenous ACL autografts of PT origin are repopulated by cells of external origin. In vitro control studies that were carried out in parallel demonstrated that PT fibroblasts could survive in tissue culture, but not in the synovial environment of the ACL. This suggests that fibroblasts from different sources have different, tissue-specific nutritional requirements.